RetinaRisk helps people determine their risk of developing diabetic retinopathy.
Healthcare entrepreneur and doctor Arna Gudmundsdottir has spent decades treating diabetics, Forbes Magazine reports.
Dr. Gudmundsdottir learned that effective treatment often involves encouraging patients to take their care into their own hands. To make this possible, she and her team began working on a method to aid diabetics in monitoring their eye health.
The team developed RetinaRisk — an app that uses an algorithm to help people determine their individualized risk of developing diabetic retinopathy, a form of vision loss that affects more than 120 million diabetics worldwide.
The algorithm considers factors such as blood glucose levels, blood pressure and gender. The company, cofounded by Dr. Gudmundsdottir with ophthalmologist Dr. Einar Steffanson, is based in Iceland, and has raised $1.8 million. In 2019 they launched RetinaRisk, and the app has now been downloaded in multiple countries by nearly 800,000 people.
With the help of the app, diabetics can frequently track their own eye health, take early action and help prevent blindness. According to RetinaRisk, early detection and treatment can prevent avoidable vision loss in 95% of cases.